Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 4/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL73316 | 1.00 | EP300 (0.46) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613438 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613262 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613265 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613471 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL3661512 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613298 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL2001842 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613604 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 | |
| SCHEMBL5613602 | 0.97 | EP300 (0.50) | EP300TSHRKMT2AMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104447162-B | A kind of preparation method of dodecylene | SINOPEC CORP. (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-104058919-B | A kind of method preparing 1-heptene | SINOPEC CORP. (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-104447162-A | Method for preparing dodecylene | CHINA PETROLEUM & CHEMICAL | 2015-03-25 | — | — | CN | claimed |
| CN-104058919-A | Preparation method for 1-heptene | CHINA PETROLEUM & CHEMICAL | 2014-09-24 | — | — | CN | claimed |
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| CN-104058919-B | A kind of method preparing 1-heptene | SINOPEC CORP. (CN) | 2016-03-30 | — | — | CN | disclosed |
| US-9193937-B2 | Mixtures of C10-C13 alkylphenyl sulfonates | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| CN-104447162-A | Method for preparing dodecylene | CHINA PETROLEUM & CHEMICAL | 2015-03-25 | — | — | CN | disclosed |
| CN-104058919-A | Preparation method for 1-heptene | CHINA PETROLEUM & CHEMICAL | 2014-09-24 | — | — | CN | disclosed |
| WO-2012138423-A1 | COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | THE PROCTER & GAMBLE COMPANY | 2012-08-23 | — | — | US | disclosed |
| US-20120208959-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| CN-101024659-A | Transition metal compound, polymerization initiator system including same and polymer production method | SUMITOMO CHEMICAL CO (JP) | 2007-08-29 | — | — | CN | disclosed |
| EP-1636154-A1 | PROCESS FOR THE PRODUCTION OF A WELL FLUIDS BASE OIL VIA METATHESIS OF ALPHA-OLEFINS | Innovene USA LLC (US) | 2006-03-22 | — | — | EP | disclosed |
| US-20050236300-A1 | Process for well fluids base oil via metathesis of alpha-olefins | INEOS USA LLC | 2005-10-27 | — | — | US | disclosed |
| US-20030236175-A1 | Process for well fluids base oil via metathesis of alpha-olefins | INNOVENE USA LLC | 2003-12-25 | — | — | US | disclosed |
| WO-2003101920-A1 | PROCESS FOR THE PRODUCTION OF A WELL FLUIDS BASE OIL VIA METATHESIS OF ALPHA-OLEFINS | BP CORPORATION NORTH AMERICA INC. (US) | 2003-12-11 | — | — | WO | disclosed |
| US-20030224945-A1 | Process for well fluids base oil via metathesis of alpha-olefins | INEOS USA LLC | 2003-12-04 | — | — | US | disclosed |
| US-4511753-A | Selective removal of vinylidene olefin from olefin mixtures | ETHYL CORPORATION (US) | 1985-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | EP300 1453/4885TSHR 4291/4885KMT2A 838/4885 |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | SMURF1, C1S, SMURF2 | EP300 121/4885TSHR 2411/4885KMT2A 2595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.